Matches in SemOpenAlex for { <https://semopenalex.org/work/W238339932> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W238339932 endingPage "E10" @default.
- W238339932 startingPage "E10" @default.
- W238339932 abstract "Statins, the most widely prescribed cholesterol-lowering drugs, are considered to be first-line therapeutics for the prevention of coronary heart disease and atherosclerosis. Statins act by inhibiting the enzyme 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, the rate-limiting enzyme in endogenous cholesterol biosynthesis, which catalyzes the reduction of HMG-CoA to mevalonic acid. Inhibition of this enzyme has proven to be effective for lowering plasma total cholesterol, low-density lipoprotein-cholesterol, and triglyceride levels in humans and can therefore be useful to treat atherosclerotic and dyslipidemic disorders. However, the clinical benefits of statins appear to extend beyond their lipid-lowering effects. Besides reducing cholesterol biosynthesis, inhibition of mevalonate by statins also leads to a reduction in the synthesis of important intermediates, such as the isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate. These intermediates are involved in the posttranslational prenylation of several proteins (e.g., Ras, Rho, Rac) that modulate a variety of cellular processes including cellular signaling, differentiation, and proliferation. Given the central role of these isoprenylated proteins in endothelial function, atherosclerotic plaque stability, platelet activity, coagulation, oxidation, and inflammatory and immunologic responses, it could be anticipated that these compounds may exert multiple beneficial effects in a broad spectrum of disorders including cardiovascular disease, osteoporosis, Alzheimer's disease and related vascular dementia, viral and bacterial infection, etc. This article summarizes these cholesterol-lowering-independent effects of statins, termed pleiotropic effects, and the underlying mechanisms, as well as the preclinical experimental approaches that would be useful to evaluate the effects of statins." @default.
- W238339932 created "2016-06-24" @default.
- W238339932 creator A5021987953 @default.
- W238339932 creator A5065549174 @default.
- W238339932 date "2007-04-18" @default.
- W238339932 modified "2023-09-23" @default.
- W238339932 title "Pleiotropic effects of statins and related pharmacological experimental approaches." @default.
- W238339932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17473899" @default.
- W238339932 hasPublicationYear "2007" @default.
- W238339932 type Work @default.
- W238339932 sameAs 238339932 @default.
- W238339932 citedByCount "5" @default.
- W238339932 countsByYear W2383399322014 @default.
- W238339932 countsByYear W2383399322017 @default.
- W238339932 crossrefType "journal-article" @default.
- W238339932 hasAuthorship W238339932A5021987953 @default.
- W238339932 hasAuthorship W238339932A5065549174 @default.
- W238339932 hasConcept C104950815 @default.
- W238339932 hasConcept C134651460 @default.
- W238339932 hasConcept C181199279 @default.
- W238339932 hasConcept C185592680 @default.
- W238339932 hasConcept C2776839432 @default.
- W238339932 hasConcept C2776990775 @default.
- W238339932 hasConcept C2778163477 @default.
- W238339932 hasConcept C2778396349 @default.
- W238339932 hasConcept C2778827360 @default.
- W238339932 hasConcept C2779716203 @default.
- W238339932 hasConcept C2779982574 @default.
- W238339932 hasConcept C2780361610 @default.
- W238339932 hasConcept C553450214 @default.
- W238339932 hasConcept C55493867 @default.
- W238339932 hasConcept C57790582 @default.
- W238339932 hasConcept C71924100 @default.
- W238339932 hasConcept C98274493 @default.
- W238339932 hasConceptScore W238339932C104950815 @default.
- W238339932 hasConceptScore W238339932C134651460 @default.
- W238339932 hasConceptScore W238339932C181199279 @default.
- W238339932 hasConceptScore W238339932C185592680 @default.
- W238339932 hasConceptScore W238339932C2776839432 @default.
- W238339932 hasConceptScore W238339932C2776990775 @default.
- W238339932 hasConceptScore W238339932C2778163477 @default.
- W238339932 hasConceptScore W238339932C2778396349 @default.
- W238339932 hasConceptScore W238339932C2778827360 @default.
- W238339932 hasConceptScore W238339932C2779716203 @default.
- W238339932 hasConceptScore W238339932C2779982574 @default.
- W238339932 hasConceptScore W238339932C2780361610 @default.
- W238339932 hasConceptScore W238339932C553450214 @default.
- W238339932 hasConceptScore W238339932C55493867 @default.
- W238339932 hasConceptScore W238339932C57790582 @default.
- W238339932 hasConceptScore W238339932C71924100 @default.
- W238339932 hasConceptScore W238339932C98274493 @default.
- W238339932 hasLocation W2383399321 @default.
- W238339932 hasOpenAccess W238339932 @default.
- W238339932 hasPrimaryLocation W2383399321 @default.
- W238339932 hasRelatedWork W1823770914 @default.
- W238339932 hasRelatedWork W1990388569 @default.
- W238339932 hasRelatedWork W1999098901 @default.
- W238339932 hasRelatedWork W2003898971 @default.
- W238339932 hasRelatedWork W2029270606 @default.
- W238339932 hasRelatedWork W2095101852 @default.
- W238339932 hasRelatedWork W2171663905 @default.
- W238339932 hasRelatedWork W238339932 @default.
- W238339932 hasRelatedWork W2417625587 @default.
- W238339932 hasRelatedWork W2946004068 @default.
- W238339932 hasVolume "11" @default.
- W238339932 isParatext "false" @default.
- W238339932 isRetracted "false" @default.
- W238339932 magId "238339932" @default.
- W238339932 workType "article" @default.